Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer

Published:2018-02 Issue:2 Volume:105 Page:418-424
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Cascone Tina,Gold Kathryn A.,Swisher Stephen G.,Liu Diane D.,Fossella Frank V.,Sepesi Boris,Pataer Apar,Weissferdt Annikka,Kalhor Neda,Vaporciyan Ara A.,Hofstetter Wayne L.,Wistuba Ignacio I.,Heymach John V.,Kim Edward S.,William William N.

Funder

Genentech, NIH

Bob Mayberry Foundation

NIH T32 Training Grant in Academic Medical Oncology

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference23 articles.

1. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

2. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

3. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant navelbine international trialist association [ANITA]): A randomised controlled trial;Douillard;Lancet Oncol,2006

4. Lung adjuvant cisplatin evaluation: A pooled analysis by the lace collaborative group;Pignon;J Clin Oncol,2008

5. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer;Roth;J Natl Cancer Inst,1994

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemoimmunotherapy for NSCLC;JAMA Oncology;2024-05-01

2. Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis;JNCI Cancer Spectrum;2024-03-23

3. Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy;Modern Pathology;2024-01

4. Perioperative Therapy for Resectable Non–Small-Cell Lung Cancer: Weighing Options for the Present and Future;JCO Oncology Practice;2023-07

5. Extended resection for potentially operable patients with stage III non–small cell lung cancer after induction treatment;The Journal of Thoracic and Cardiovascular Surgery;2022-12